These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34248244)

  • 1. Tracking the maturity of industry 4.0: the perspective of a real scenario.
    Alcácer V; Rodrigues C; Carvalho H; Cruz-Machado V
    Int J Adv Manuf Technol; 2021; 116(7-8):2161-2181. PubMed ID: 34248244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Industry 4.0 Readiness Calculation-Transitional Strategy Definition by Decision Support Systems.
    Trstenjak M; Opetuk T; Cajner H; Hegedić M
    Sensors (Basel); 2022 Feb; 22(3):. PubMed ID: 35161929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Readiness levels of Industry 4.0 technologies applied to aircraft manufacturing-a review, challenges and trends.
    Zutin GC; Barbosa GF; de Barros PC; Tiburtino EB; Kawano FLF; Shiki SB
    Int J Adv Manuf Technol; 2022; 120(1-2):927-943. PubMed ID: 35465449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a readiness model for industry 4.0 using Analytical Hierarchy process and fuzzy inference system: Bangladesh perspective.
    Faisal SMF; Chandra Banik S; Sen Gupta P
    Heliyon; 2024 Jan; 10(1):e23664. PubMed ID: 38173499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research on predicting the driving forces of digital transformation in Chinese media companies based on machine learning.
    Wang Z; Li Y; Zhao X; Wang Y; Xiao Z
    Sci Rep; 2024 Mar; 14(1):7286. PubMed ID: 38538765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Awareness, adoption readiness and challenges of railway 4.0 technologies in a developing economy.
    Awodele IA; Mewomo MC; Municio AMG; Chan APC; Darko A; Taiwo R; Olatunde NA; Eze EC; Awodele OA
    Heliyon; 2024 Feb; 10(4):e25934. PubMed ID: 38384510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment and governance of industrial internet maturity in the building materials industry using the entropy weight method and factor analysis.
    Heng Y; Sheng C; Youxue H
    Heliyon; 2023 Aug; 9(8):e18650. PubMed ID: 37593604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel maturity index for assessing medical device startups.
    Richmond FJ; Zapotoczny G; Green B; Lokappa S; Rudnick K; Espinoza J;
    J Clin Transl Sci; 2022; 6(1):e99. PubMed ID: 36106131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the industrial readiness for adoption of industry 4.0 in Nepal: A structural equation model analysis.
    Rajbhandari S; Devkota N; Khanal G; Mahato S; Paudel UR
    Heliyon; 2022 Feb; 8(2):e08919. PubMed ID: 35243054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baby boomers' adoption of consumer health technologies: survey on readiness and barriers.
    LeRouge C; Van Slyke C; Seale D; Wright K
    J Med Internet Res; 2014 Sep; 16(9):e200. PubMed ID: 25199475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lean 4.0 tools and technologies to improve companies' maturity level: the COVID-19 context.
    Najwa E; Bertrand R; Yassine M; Fernandes G; Abdeen M; Souad S
    Procedia Comput Sci; 2022; 196():207-216. PubMed ID: 35035618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing an interplay among the psychological barriers for the adoption of industry 4.0 phenomenon.
    Mahmood A; Arshad Ali A; Nazam M; Nazim M
    PLoS One; 2021; 16(8):e0255115. PubMed ID: 34339448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoption of Industry 4.0 technologies by organizations: a maturity levels perspective.
    Queiroz MM; Fosso Wamba S; Chiappetta Jabbour CJ; Lopes de Sousa Jabbour AB; Machado MC
    Ann Oper Res; 2022 Oct; ():1-27. PubMed ID: 36217321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomanufacturing readiness levels [BRL]-A shared vocabulary for biopharmaceutical technology development and commercialization.
    Kedia SB; Baker JC; Carbonell RG; Lee KH; Roberts CJ; Erickson J; Schiel JE; Rogers K; Schaefer G; Pluschkell S
    Biotechnol Bioeng; 2022 Dec; 119(12):3526-3536. PubMed ID: 36071569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Speeding Up the Implementation of Industry 4.0 with Management Tools: Empirical Investigations in Manufacturing Organizations.
    Črešnar R; Potočan V; Nedelko Z
    Sensors (Basel); 2020 Jun; 20(12):. PubMed ID: 32575501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstrating the value of digital health: Guidance on contextual evidence gathering for companies in different stages of maturity.
    Halminen O; Chen A; Tenhunen H; Lillrank P
    Health Serv Manage Res; 2021 Feb; 34(1):13-20. PubMed ID: 33291977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stakeholders, innovative business models for the circular economy and sustainable performance of firms in an emerging economy facing institutional voids.
    Chiappetta Jabbour CJ; Seuring S; Lopes de Sousa Jabbour AB; Jugend D; De Camargo Fiorini P; Latan H; Izeppi WC
    J Environ Manage; 2020 Jun; 264():110416. PubMed ID: 32217311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional development potentials of Industry 4.0: Open data indicators of the Industry 4.0+ model.
    Czvetkó T; Honti G; Abonyi J
    PLoS One; 2021; 16(4):e0250247. PubMed ID: 33872343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.